Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Feb;44(2):482-492.
doi: 10.1007/s00261-018-1745-3.

Inter-reader agreement of magnetic resonance imaging proton density fat fraction and its longitudinal change in a clinical trial of adults with nonalcoholic steatohepatitis

Affiliations
Randomized Controlled Trial

Inter-reader agreement of magnetic resonance imaging proton density fat fraction and its longitudinal change in a clinical trial of adults with nonalcoholic steatohepatitis

Jonathan C Hooker et al. Abdom Radiol (NY). 2019 Feb.

Abstract

Purpose: To determine the inter-reader agreement of magnetic resonance imaging proton density fat fraction (PDFF) and its longitudinal change in a clinical trial of adults with nonalcoholic steatohepatitis (NASH).

Study type: We performed a secondary analysis of a placebo-controlled randomized clinical trial of a bile acid sequestrant in 45 adults with NASH. A six-echo spoiled gradient-recalled-echo magnitude-based fat quantification technique was performed at 3 T. Three independent readers measured MRI-PDFF by placing one primary and two additional regions of interest (ROIs) in each segment at both time points. Cross-sectional agreement between the three readers was evaluated using intra-class correlation coefficients (ICCs) and coefficients of variation (CV). Additionally, we used Bland-Altman analyses to examine pairwise agreement between the three readers at baseline, end of treatment (EOT), and for longitudinal change.

Results: Using all ROIs by all readers, mean PDFF at baseline, at EOT, and mean change in PDFF was 16.1%, 16.0%, and 0.07%, respectively. The 27-ROI PDFF measurements had 0.998 ICC and 1.8% CV at baseline, 0.998 ICC and 1.8% CV at EOT, and 0.997 ICC for longitudinal change. The 9-ROI PDFF measurements had corresponding values of 0.997 and 2.6%, 0.996 and 2.4%, and 0.994. Using 27 ROIs, the magnitude of the bias between readers for whole-liver PDFF measurement ranged from 0.03% to 0.06% points at baseline, 0.01% to 0.07% points at EOT, and 0.01% to 0.02% points for longitudinal change.

Conclusion: Inter-reader agreement for measuring whole-liver PDFF and its longitudinal change is high. 9-ROI measurements have only slightly lower agreement than 27-ROI measurements.

Keywords: Inter-reader agreement; Liver; Proton density fat fraction (PDFF); Quantitative imaging biomarker; Region of interest; Reproducibility.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest:

Jonathan C. Hooker declares that he has no conflict of interest.

Dr. Gavin Hamilton declares that he has no conflict of interest.

Charlie C. Park declares that he has no conflict of interest.

Dr. Steven Liao declares that he has no conflict of interest.

Tanya Wolfson declares that she has no conflict of interest.

Dr. Soudabeh Fazeli Dehkordy declares that she has no conflict of interest.

Dr. Cheng William Hong declares that he has no conflict of interest.

Dr. Adrija Mamidipalli declares that she has no conflict of interest.

Dr. Anthony Gamst declares that he has no conflict of interest.

Figures

Fig. 1
Fig. 1
shows the liver covered from dome (top left) to tip (bottom right) on the magnitude-based MRI proton density fat fraction (PDFF) maps. The 27 regions of interest (ROIs) placed by each reader are shown, color coded by reader. The primary ROI in each segment has a continuous border. The secondary ROIs have dashed borders. Note that the scale bar reflects the fat-water signal dominance ambiguity using magnitude reconstruction.
Fig. 2
Fig. 2
illustrates the results of the Bland-Altman analysis for measuring PDFF at baseline and its change longitudinally for 9- and 27-ROI methods. Plots for measuring PDFF at end of treatment (not shown) are similar to those at baseline.

References

    1. Tang A, Tan J, Sun M, et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 2013;267(2):422–431. - PMC - PubMed
    1. Tang A, Desai A, Hamilton G, et al. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 2015;274(2):416–425. - PMC - PubMed
    1. Schwimmer JB, Middleton MS, Behling C, et al. Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease. Hepatology 2015;61(6):1887–1895. - PMC - PubMed
    1. Idilman IS, Aniktar H, Idilman R, et al. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 2013;267(3):767–775. - PubMed
    1. Rehm JL, Wolfgram PM, Hernando D, Eickhoff JC, Allen DB, Reeder SB. Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women. Eur Radiol 2015;25(10):2921–2930. - PMC - PubMed

Publication types

LinkOut - more resources